247 related articles for article (PubMed ID: 31097083)
1. Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening.
Liang F; Wu C; Gu H; Zhu M; Xuan Z; Jiang Y; Chen H; Fu C; Zheng Y
Lung Cancer; 2019 Jun; 132():114-118. PubMed ID: 31097083
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
3. [The incidence and mortality of lung cancer among residents in Yangpu district of Shanghai from 2002 to 2010].
Han X; Qiao P; Xie M; Zhao J; Huang CX; Zhang HW; Cao GW
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):712-8. PubMed ID: 23159089
[TBL] [Abstract][Full Text] [Related]
4. [Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].
Liao ML; Chen ZW; Zheng Y; Wu CX; Lu S; Yu YF; Jian H; Cheng BJ
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1876-80. PubMed ID: 17923007
[TBL] [Abstract][Full Text] [Related]
5. [Lung cancer screening in urban Beijing from 2014 to 2019].
Yang L; Zhang X; Liu S; Li HC; Li QY; Wang N; Ji JF
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):339-345. PubMed ID: 33730825
[No Abstract] [Full Text] [Related]
6. Breast cancer incidence and mortality: trends over 40 years among women in Shanghai, China.
Huang Z; Wen W; Zheng Y; Gao YT; Wu C; Bao P; Wang C; Gu K; Peng P; Gong Y; Zhang M; Xiang Y; Zhong W; Jin F; Xiang YB; Shu XO; Beeghly-Fadiel A
Ann Oncol; 2016 Jun; 27(6):1129-1134. PubMed ID: 27013394
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
8. The Introduction of Low-Dose CT Imaging and Lung Cancer Overdiagnosis in Chinese Women.
Wang M; Lin S; He N; Yang C; Zhang R; Liu X; Suo C; Lin T; Chen H; Xu W
Chest; 2023 Jan; 163(1):239-250. PubMed ID: 35998705
[TBL] [Abstract][Full Text] [Related]
9. [The incidence and mortality of lung cancer in China, 2014].
Sun KX; Zheng RS; Zeng HM; Zhang SW; Zou XN; Gu XY; Xia CF; Yang ZX; Li H; Chen WQ; He J
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):805-811. PubMed ID: 30481929
[No Abstract] [Full Text] [Related]
10. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
11. [Trend analysis and prediction of cancer incidence in China].
Chen WQ; Zheng RS; Zeng HM; Zhang SW; Li N; Zou XN; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jul; 46(7):581-6. PubMed ID: 22943910
[TBL] [Abstract][Full Text] [Related]
12. [Analysis on the alterative trend of colorectal cancer mortality from 1999 to 2015 in Tianjin of China].
Wang DZ; Zhang S; Zhang H; Shen CF; Zhang Y; Song GD; Pang S; Wang C; Wang Z; Jiang GH
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):579-586. PubMed ID: 31238638
[No Abstract] [Full Text] [Related]
13. [China National Lung Cancer Screening Guideline with Low-dose Computed
Tomography (2018 version)].
Zhou Q; Fan Y; Wang Y; Qiao Y; Wang G; Huang Y; Wang X; Wu N; Zhang G; Zheng X; Bu H; Li Y; Wei S; Chen L; Hu C; Shi Y; Sun Y
Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):67-75. PubMed ID: 29526173
[TBL] [Abstract][Full Text] [Related]
14. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
[TBL] [Abstract][Full Text] [Related]
15. Incidence and mortality rates of lung cancer in Qingdao, China (2013-2017).
Sun X; Xu X; Wang Y; Hou B; Luo T; Meng D; Wang S; Ning F
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e73-e78. PubMed ID: 33765360
[TBL] [Abstract][Full Text] [Related]
16. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.
Pastorino U; Rossi M; Rosato V; Marchianò A; Sverzellati N; Morosi C; Fabbri A; Galeone C; Negri E; Sozzi G; Pelosi G; La Vecchia C
Eur J Cancer Prev; 2012 May; 21(3):308-15. PubMed ID: 22465911
[TBL] [Abstract][Full Text] [Related]
17. [Trend analysis on incidence and age at diagnosis for lung cancer in cancer registration areas of China, 2000-2014].
Zhang SW; Zheng RS; Yang ZX; Zeng HM; Sun KX; Gu XY; Li H; Chen WQ; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jun; 52(6):579-585. PubMed ID: 29886678
[No Abstract] [Full Text] [Related]
18. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
[TBL] [Abstract][Full Text] [Related]
19. Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009.
Qi D; Wu C; Liu F; Gu K; Shi Z; Lin X; Tao S; Xu W; Brendler CB; Zheng Y; Xu J
Prostate; 2015 Oct; 75(14):1662-8. PubMed ID: 26184773
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of lung cancer and lung cancer screening programs in China and the United States.
Yang D; Liu Y; Bai C; Wang X; Powell CA
Cancer Lett; 2020 Jan; 468():82-87. PubMed ID: 31600530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
